Apr 19, 2010
SuppreMol Receives U.S. Orphan Drug Designation for SM101

Apr 12, 2010
SuppreMol initiates Phase Ib/IIa clinical trial with its lead candidate SM101

Feb 08, 2010
SuppreMol appoints Dr. Robert Phelps as Head of Business Development & Licensing

September 15-17, 2010
BioPharma America 2010, Boston, MA, USA

Corporate Fact Sheet (en)
Corporate Fact Sheet (de)
Press Resources

Prof. Peter Buckel im Video-Interview

	Corporate Fact Sheet (english) (92.58 kb)
	Corporate Fact Sheet (german) (92.95 kb)
	BioCentury Profile, 20 February 2006 (33 kb)
	Hi-res version of the Suppremol Logo (60.04 kb)
	MPI-Newsletter-No.3-2009-english (90.52 kb)
	MPI-Newsletter-No.3-2009-deutsch (92 kb)
	(92.95 kb)